+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemotherapy Agent"

Advanced Gastric Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
AXL Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

AXL Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • March 2025
  • 80 Pages
  • Global
From
Adrenocortical Carcinoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Adrenocortical Carcinoma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 71 Pages
  • Global
From
Synovial Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Synovial Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2024 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
From
Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 240 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
IPSC derived NK cells - Pipeline Insight, 2024 - Product Thumbnail Image

IPSC derived NK cells - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
Peritoneal cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Peritoneal cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
From
From
Hepatic Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatic Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
Loading Indicator

The Chemotherapy Agent market within the Healthcare Services sector is a rapidly growing industry. It is composed of a variety of products and services that are used to treat cancer and other diseases. These products and services include drugs, medical devices, and other treatments. The market is driven by the increasing prevalence of cancer and other diseases, as well as the development of new treatments and technologies. The Chemotherapy Agent market is highly competitive, with many companies offering a wide range of products and services. Companies in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Roche. These companies are constantly innovating and developing new products and services to meet the needs of patients and healthcare providers. Show Less Read more